Skip to content
lifestyle.newsblaze.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Acumen Pharmaceuticals, Inc.
Acumen Pharmaceuticals Presents Studies on Enhanced Brain Delivery™, Biomarker Research, and Novel Antibodies at Advances in Alzheimer’s Treatment at International Conference on Alzheimer’s and Parkinson’s Diseases 2026
March 17, 2026
Acumen Pharmaceuticals Announces $35.75 Million Private Placement to Advance Potential Best-in-Class Molecules from Amyloid Beta Oligomer-Selective Enhanced Brain Delivery Portfolio
March 16, 2026
Acumen Pharmaceuticals to Showcase Advances in Alzheimer’s Treatment at International Conference on Alzheimer’s and Parkinson’s Diseases 2026
March 3, 2026
←
Previous Page
1
2